Browsing by Author Weiss, Jocelyn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2002Insulin-like Growth Factor-II/Mannose 6-Phosphate Receptor Overexpression Reduces Growth of Choriocarcinoma Cells in Vitro and in VivoFirth, Sue; Scott, Carolyn; Hettiaratchi, Anusha; O'Gorman, David B.; Weiss, Jocelyn; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteInsulin-like Growth Factor-II/Mannose 6-Phosphate Receptor Overexpression Reduces Growth of Choriocarcinoma Cells in Vitro and in Vivo, Endocrinology, vol.143,(11),2002,pp 4287-4294
2011The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemiaBendall, Linda; Bradstock, Kenneth; Cisterne, Adam; Saunders, Philip; Weiss, Jocelyn; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteThe mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia, Haematologica: the hematology journal, vol.96, 1, 2011,pp 69-77
2015microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaClarke, Stephen; Feeney, Alex L; Gill, Anthony; Glover, Anthony; Ip, Julian; Kim, Edward; Reid, Glen; Robinson, Bruce; Sidhu, Stan; Zhao, Jing; Brahmbhatt, Himanshu; MacDiarmid, Jennifer; Mugridge, Nancy; Soon, Patsy; Weiss, Jocelyn; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Pathology; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstitutemicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma, Oncotarget, vol.6, 34, 2015,pp 36675-36688
2015miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCooper, Wendy Anne; Edelman, John (James); Hanh, Jacky; Kao, Steven; Kirschner, Michaela; Linton, Anthony; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Amaro-Mugridge, Nancy; Brahmbhatt, Himanshu; Cheng, YuenYee; Klebe, Sonja; Lin, Ruby C. Y.; MacDiarmid, Jennifer; McCaughan, Brian; Weiss, Jocelyn; Williams, Marissa; Wright, Casey; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstitutemiR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma, Oncotarget, vol.6, 27, 2015,pp 23480-23495
2014mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell deathBaraz, Rana; Basnett, Jordan; Bendall, Linda; Bradstock, Kenneth; Cisterne, Adam; Hewson, John; Saunders, Philip; Thien, Marilyn; Weiss, Jocelyn; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Concord Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstitutemTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death, PloS One, vol.9, 7, 2014,pp 1-10
2013RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristineBaraz, Rana; Bendall, Linda; Bradstock, Kenneth; Saunders, Philip; Weiss, Jocelyn; Welschinger, Robert; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Infectious DiseasesRAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine, Oncogene, vol.32, 40, 2013,pp 4789-4797